Infarction: all 2,542 studies
Page 26 of 26. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Insulin and Biogenic Amines in Cardiovascular DiseaseCompletedNCT00005194
- Clinical Course of Coronary Artery Disease Among BlacksCompletedNCT00005191
- Carotid Atherosclerosis Follow-up StudyCompletedNCT00005189
- Myocardial Infarction and Non-contraceptive Estrogen UseCompletedNCT00005185
- Health Professionals Follow-up StudyCompletedNCT00005182
- Myocardial Infarction and Past Oral Contraceptive UseCompletedNCT00005173
- Minnesota Heart Health ProgramCompletedNCT00005150
- Coronary Heart Disease Incidence, Mortality, and Risk Factor RelationshipsCompletedNCT00005148
- Minnesota Heart Survey - Risk Factor SurveyCompletedNCT00005145
- Stanford Five-City Multifactor Risk Reduction StudyCompletedNCT00005143
- Evans County StudiesCompletedNCT00005122
- Vitamin Therapy for Prevention of StrokeCompletedNCT00004734Phase 3
- Aspirin Or Warfarin To Prevent StrokeTerminatedNCT00004728Phase 3
- Antiplatelet Therapy to Prevent Stroke in African AmericansCompletedNCT00004727Phase 4
- Public Access Defibrillation (PAD) Community TrialCompletedNCT00004560Phase 3
- MRI Evaluation of Chest PainCompletedNCT00001961Phase 2
- Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media ThicknessCompletedNCT00001904
- Evaluation of Treated and Untreated StrokeCompletedNCT00001840
- The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular FunctionCompletedNCT00001629Phase 3
- The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular FunctionCompletedNCT00001628Phase 3
- Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood DonorsCompletedNCT00001589
- Magnesium in Coronaries (MAGIC)CompletedNCT00000610Phase 3
- NHLBI Type II Coronary Intervention StudyCompletedNCT00000594Phase 3
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)CompletedNCT00000558Phase 3
- Enhancing Recovery in Coronary Heart Disease (ENRICHD) PatientsCompletedNCT00000557Phase 3
- Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.CompletedNCT00000552Phase 3
- Rapid Early Action for Coronary Treatment (REACT)CompletedNCT00000550Phase 3
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)CompletedNCT00000542Phase 3
- Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)CompletedNCT00000541Phase 2
- Montreal Heart Attack Readjustment Trial (M-HART)CompletedNCT00000533Phase 3
- Intravenous Streptokinase in Acute Myocardial InfarctionCompletedNCT00000507Phase 3
- Thrombolysis in Myocardial Infarction (TIMI)CompletedNCT00000505Phase 3
- Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary ArteriesCompletedNCT00000503Phase 3
- Evaluation of SC-V Versus Conventional CPRCompletedNCT00000502Phase 3
- Multicenter Investigation of Limitation of Infarct Size (MILIS)CompletedNCT00000493Phase 3
- Aspirin-Myocardial Infarction Study (AMIS)CompletedNCT00000491Phase 3
- Program on Surgical Control of Hyperlipidemias (POSCH)CompletedNCT00000490Phase 3
- Coronary Drug Project Mortality SurveillanceCompletedNCT00000483Not applicable
- Coronary Drug ProjectCompletedNCT00000482Phase 3
- Thrombolysis in Myocardial Ischemia Trial (TIMI III)CompletedNCT00000472Phase 3
- Myocardial Infarction Triage and Intervention Project (MITI)CompletedNCT00000468Phase 3
- Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)CompletedNCT00000464Phase 3